ReP USP - Resultado da busca

Artigo de periodico
Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment (2004)
Spósito, Andrei Carvalho; Lemos, Pedro Alves; Santos, Raul D.; Hueb, Whady; Vinagre, Carmen Guilherme Christiano de Matos; Quintella, Edgard; Carneiro, Otavio; Chapman, M. John; Ramires, José Antônio Franchini; Maranhão, Raul Cavalcante
Fonte: Journal of the American College of Cardiology. Unidades: FCF, FM
Assuntos: DOENÇAS CARDIOVASCULARES, LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, v. 43, n. 12, p. 2225-2232, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2003.11.065. Acesso em: 11 nov. 2024.
APA
Spósito, A. C., Lemos, P. A., Santos, R. D., Hueb, W., Vinagre, C. G. C. de M., Quintella, E., et al. (2004). Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, 43( 12), 2225-2232. doi:10.1016/j.jacc.2003.11.065
NLM
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
Vancouver
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
Artigo de periodico
Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction (2004)
Chacra, Ana Paula Marte; Santos, Raul D.; Amâncio, Rosângela Fernandes; Schreiber, Roberto; Ramires, José Antônio Franchini; Maranhão, Raul Cavalcante
Fonte: International Journal of Cardiology. Unidades: FCF, FM
Assuntos: LIPOPROTEÍNAS, INFARTO DO MIOCÁRDIO, CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHACRA, Ana Paula Marte et al. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction. International Journal of Cardiology, v. 93, n. 2-3, p. 181-187, 2004Tradução . . Disponível em: https://doi.org/10.1016/s0167-5273(03)00159-1. Acesso em: 11 nov. 2024.
APA
Chacra, A. P. M., Santos, R. D., Amâncio, R. F., Schreiber, R., Ramires, J. A. F., & Maranhão, R. C. (2004). Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction. International Journal of Cardiology, 93( 2-3), 181-187. doi:10.1016/s0167-5273(03)00159-1
NLM
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction [Internet]. International Journal of Cardiology. 2004 ; 93( 2-3): 181-187.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0167-5273(03)00159-1
Vancouver
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction [Internet]. International Journal of Cardiology. 2004 ; 93( 2-3): 181-187.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0167-5273(03)00159-1
Artigo de periodico
Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects (2004)
Faludi, André Arpad; Aldrighi, José Mendes; Bertolami, Marcelo Chiara; Saleh, Mohamed H.; Silva, Renata Alves; Nakamura, Yara; Pereira, Isabela Rosier Olimpio; Abdalla, Dulcinéia Saes Parra ; Ramires, José Antônio Franchini; Sousa, José Eduardo M. R.
Fonte: Atherosclerosis. Unidades: FCF, FSP, FM
Assuntos: HIPERCOLESTEROLEMIA, HORMÔNIOS PROGESTACIONAIS, MENOPAUSA, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALUDI, André Arpad et al. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis, v. 177, n. 1, p. 89-96, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2004.05.030. Acesso em: 11 nov. 2024.
APA
Faludi, A. A., Aldrighi, J. M., Bertolami, M. C., Saleh, M. H., Silva, R. A., Nakamura, Y., et al. (2004). Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis, 177( 1), 89-96. doi:10.1016/j.atherosclerosis.2004.05.030
NLM
Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Pereira IRO, Abdalla DSP, Ramires JAF, Sousa JEMR. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects [Internet]. Atherosclerosis. 2004 ; 177( 1): 89-96.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.030
Vancouver
Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Pereira IRO, Abdalla DSP, Ramires JAF, Sousa JEMR. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects [Internet]. Atherosclerosis. 2004 ; 177( 1): 89-96.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.030
Artigo de periodico
Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins (2003)
Spósito, Andrei Carvalho; Santos, Raul D.; Amâncio, Rosângela F.; Ramires, José Antônio Franchini; Chapman, M. John; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Unidades: FCF, FM
Assuntos: DOENÇAS CARDIOVASCULARES, CARDIOLOGIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, v. 166, n. 2, p. 311-321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(02)00334-9. Acesso em: 11 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Amâncio, R. F., Ramires, J. A. F., Chapman, M. J., & Maranhão, R. C. (2003). Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, 166( 2), 311-321. doi:10.1016/s0021-9150(02)00334-9
NLM
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
Vancouver
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
Artigo de periodico
Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations (2002)
Salazar, Luís Antônio; Hirata, Mario Hiroyuki ; Cavalli, Selma Andrea; Nakandakare, Edna Regina; Forti, Neusa Assumpta; Diament, Jayme; Giannini, Sérgio Diogo; Bertolami, Marcelo Chiara; Hirata, Rosario Dominguez Crespo
Fonte: Human Mutation. Unidades: FCF, FM
Assuntos: GENÉTICA, HIPERCOLESTEROLEMIA (AVALIAÇÃO), MUTAÇÃO GENÉTICA (IDENTIFICAÇÃO), TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALAZAR, Luís Antônio et al. Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations. Human Mutation, v. 19, n. 4, p. 462-463, 2002Tradução . . Disponível em: https://doi.org/10.1002/humu.9032. Acesso em: 11 nov. 2024.
APA
Salazar, L. A., Hirata, M. H., Cavalli, S. A., Nakandakare, E. R., Forti, N. A., Diament, J., et al. (2002). Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations. Human Mutation, 19( 4), 462-463. doi:10.1002/humu.9032
NLM
Salazar LA, Hirata MH, Cavalli SA, Nakandakare ER, Forti NA, Diament J, Giannini SD, Bertolami MC, Hirata RDC. Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations [Internet]. Human Mutation. 2002 ; 19( 4): 462-463.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/humu.9032
Vancouver
Salazar LA, Hirata MH, Cavalli SA, Nakandakare ER, Forti NA, Diament J, Giannini SD, Bertolami MC, Hirata RDC. Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations [Internet]. Human Mutation. 2002 ; 19( 4): 462-463.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/humu.9032
Artigo de periodico
LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease (2002)
Spósito, Andrei Carvalho; Santos, Raul D.; Hueb, Whady; Ventura, Laura Ines; Vinagre, Carmen G. C.; Ramires, José Antônio Franchini; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Unidades: FCF, FM
Assuntos: BIOQUÍMICA, PROTEÍNAS (METABOLISMO), HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, PLASMA (CONCENTRAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, v. 161, n. 2, p. 447-453, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(01)00661-x. Acesso em: 11 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Hueb, W., Ventura, L. I., Vinagre, C. G. C., Ramires, J. A. F., & Maranhão, R. C. (2002). LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, 161( 2), 447-453. doi:10.1016/s0021-9150(01)00661-x
NLM
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
Vancouver
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
Artigo de periodico
Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women (2001)
Spósito, Andrei Carvalho; Mansur, Antonio de Padua; Maranhão, Raul Cavalcante ; Martinez, Tania R. L.; Aldrighi, José Mendes; Ramires, José Antônio Franchini
Fonte: Maturitas. Unidades: FCF, FSP, FM
Assuntos: MENOPAUSA, DOENÇAS CARDIOVASCULARES, COMPOSTOS ORGÂNICOS (FISIOLOGIA), BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women. Maturitas, v. 39, n. 3, p. 203-208, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0378-5122(01)00223-7. Acesso em: 11 nov. 2024.
APA
Spósito, A. C., Mansur, A. de P., Maranhão, R. C., Martinez, T. R. L., Aldrighi, J. M., & Ramires, J. A. F. (2001). Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women. Maturitas, 39( 3), 203-208. doi:10.1016/s0378-5122(01)00223-7
NLM
Spósito AC, Mansur A de P, Maranhão RC, Martinez TRL, Aldrighi JM, Ramires JAF. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women [Internet]. Maturitas. 2001 ; 39( 3): 203-208.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0378-5122(01)00223-7
Vancouver
Spósito AC, Mansur A de P, Maranhão RC, Martinez TRL, Aldrighi JM, Ramires JAF. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women [Internet]. Maturitas. 2001 ; 39( 3): 203-208.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/s0378-5122(01)00223-7

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Indexado em